Geode Capital Management
TMO icon

Geode Capital Management’s Thermo Fisher Scientific TMO Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$3.27B Sell
8,114,787
-12,399
-0.2% -$5M 0.23% 71
2025
Q1
$4.03B Buy
8,127,186
+269,801
+3% +$134M 0.32% 46
2024
Q4
$4.08B Buy
7,857,385
+197,442
+3% +$102M 0.32% 43
2024
Q3
$4.72B Buy
7,659,943
+127,564
+2% +$78.6M 0.38% 36
2024
Q2
$4.15B Buy
7,532,379
+37,188
+0.5% +$20.5M 0.36% 38
2024
Q1
$4.34B Buy
7,495,191
+203,298
+3% +$118M 0.4% 36
2023
Q4
$3.86B Buy
7,291,893
+173,554
+2% +$91.8M 0.4% 37
2023
Q3
$3.59B Buy
7,118,339
+139,470
+2% +$70.4M 0.43% 34
2023
Q2
$3.63B Sell
6,978,869
-6,715
-0.1% -$3.49M 0.43% 37
2023
Q1
$4.02B Buy
6,985,584
+106,233
+2% +$61.1M 0.52% 28
2022
Q4
$3.78B Buy
6,879,351
+123,256
+2% +$67.7M 0.53% 27
2022
Q3
$3.42B Buy
6,756,095
+115,628
+2% +$58.6M 0.52% 27
2022
Q2
$3.6B Buy
6,640,467
+99,048
+2% +$53.7M 0.53% 28
2022
Q1
$3.85B Buy
6,541,419
+137,614
+2% +$81.1M 0.48% 30
2021
Q4
$4.26B Buy
6,403,805
+214,375
+3% +$143M 0.51% 26
2021
Q3
$3.53B Buy
6,189,430
+119,371
+2% +$68M 0.47% 30
2021
Q2
$3.05B Buy
6,070,059
+173,240
+3% +$87.1M 0.42% 41
2021
Q1
$2.68B Buy
5,896,819
+93,794
+2% +$42.7M 0.41% 40
2020
Q4
$2.7B Buy
5,803,025
+193,906
+3% +$90.1M 0.45% 36
2020
Q3
$2.47B Buy
5,609,119
+73,434
+1% +$32.3M 0.48% 35
2020
Q2
$2B Buy
5,535,685
+76,104
+1% +$27.5M 0.43% 40
2020
Q1
$1.54B Sell
5,459,581
-81,340
-1% -$23M 0.4% 48
2019
Q4
$1.8B Buy
5,540,921
+151,622
+3% +$49.1M 0.38% 47
2019
Q3
$1.57B Buy
5,389,299
+89,130
+2% +$25.9M 0.37% 51
2019
Q2
$1.55B Buy
5,300,169
+10,130
+0.2% +$2.97M 0.38% 49
2019
Q1
$1.45B Buy
5,290,039
+392,325
+8% +$107M 0.37% 54
2018
Q4
$1.09B Buy
4,897,714
+422,625
+9% +$94.4M 0.34% 56
2018
Q3
$1.09B Buy
4,475,089
+126,552
+3% +$30.8M 0.31% 63
2018
Q2
$899M Buy
4,348,537
+219,072
+5% +$45.3M 0.28% 66
2018
Q1
$850M Buy
4,129,465
+212,244
+5% +$43.7M 0.28% 66
2017
Q4
$742M Buy
3,917,221
+158,961
+4% +$30.1M 0.25% 76
2017
Q3
$710M Buy
3,758,260
+157,011
+4% +$29.6M 0.26% 75
2017
Q2
$627M Buy
3,601,249
+38,806
+1% +$6.76M 0.25% 79
2017
Q1
$546M Buy
3,562,443
+232,624
+7% +$35.7M 0.22% 87
2016
Q4
$469M Buy
3,329,819
+134,030
+4% +$18.9M 0.22% 90
2016
Q3
$507M Buy
3,195,789
+140,777
+5% +$22.4M 0.26% 73
2016
Q2
$451M Sell
3,055,012
-65,296
-2% -$9.63M 0.25% 80
2016
Q1
$441K Buy
3,120,308
+40,214
+1% +$5.68K 0.23% 83
2015
Q4
$436M Buy
3,080,094
+10,952
+0.4% +$1.55M 0.25% 77
2015
Q3
$375M Buy
3,069,142
+26,537
+0.9% +$3.24M 0.23% 86
2015
Q2
$394M Buy
3,042,605
+22,784
+0.8% +$2.95M 0.22% 90
2015
Q1
$405M Buy
3,019,821
+78,900
+3% +$10.6M 0.23% 90
2014
Q4
$368M Buy
2,940,921
+117,735
+4% +$14.7M 0.22% 94
2014
Q3
$343M Sell
2,823,186
-24,048
-0.8% -$2.92M 0.22% 92
2014
Q2
$336M Sell
2,847,234
-73,065
-3% -$8.62M 0.22% 95
2014
Q1
$351M Buy
2,920,299
+307,116
+12% +$36.9M 0.24% 86
2013
Q4
$291M Buy
2,613,183
+135,857
+5% +$15.1M 0.2% 101
2013
Q3
$228M Buy
2,477,326
+101,896
+4% +$9.39M 0.18% 113
2013
Q2
$201M Buy
+2,375,430
New +$201M 0.18% 117